Acute myeloid leukemia (AML) is one of the most common types of leukaemia among adults. A major challenge in developing chimeric antigen receptor (CAR)-engineered cell therapies for acute myeloid ...

They detail their findings in a paper, "Cytokine-mediated CAR T therapy resistance in AML," published in Nature Medicine. While the therapy was successfully administered to most participants ...

The US National Institute of Standards and Technology (NIST) has warned that there are significant challenges and limitations ...

Acute myeloid leukemia (AML) is a type of blood and bone marrow cancer. AML can affect people of any age, but it is most common in adults. AML occurs when bone marrow produces abnormal blood cells ...